Unveiling the neuroinflammatory pathogenesis of persistent functional dyspepsia in H. pylori infection : Insights on MMP-9 as a therapeutic target
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:13 |
|---|---|
| Enthalten in: |
Clinical and translational medicine - 13(2023), 11 vom: 29. Nov., Seite e1456 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Tseng, Yujen [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
EC 3.4.24.35 |
|---|
| Anmerkungen: |
Date Completed 31.10.2023 Date Revised 29.11.2023 published: Print Citation Status MEDLINE |
|---|
| doi: |
10.1002/ctm2.1456 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM363916962 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM363916962 | ||
| 003 | DE-627 | ||
| 005 | 20231226094344.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1002/ctm2.1456 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1212.xml |
| 035 | |a (DE-627)NLM363916962 | ||
| 035 | |a (NLM)37899692 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Tseng, Yujen |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Unveiling the neuroinflammatory pathogenesis of persistent functional dyspepsia in H. pylori infection |b Insights on MMP-9 as a therapeutic target |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 31.10.2023 | ||
| 500 | |a Date Revised 29.11.2023 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Letter | |
| 650 | 4 | |a Research Support, Non-U.S. Gov't | |
| 650 | 7 | |a Matrix Metalloproteinase 9 |2 NLM | |
| 650 | 7 | |a EC 3.4.24.35 |2 NLM | |
| 700 | 1 | |a Lin, Lingxi |e verfasserin |4 aut | |
| 700 | 1 | |a Mo, Shaocong |e verfasserin |4 aut | |
| 700 | 1 | |a Zhao, Suhan |e verfasserin |4 aut | |
| 700 | 1 | |a Shen, Qiwei |e verfasserin |4 aut | |
| 700 | 1 | |a Song, Huan |e verfasserin |4 aut | |
| 700 | 1 | |a Cui, Haoshu |e verfasserin |4 aut | |
| 700 | 1 | |a Zhang, Jun |e verfasserin |4 aut | |
| 700 | 1 | |a Zheng, Wanwei |e verfasserin |4 aut | |
| 700 | 1 | |a Luo, Zhongguang |e verfasserin |4 aut | |
| 700 | 1 | |a Luo, Feifei |e verfasserin |4 aut | |
| 700 | 1 | |a Liu, Jie |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Clinical and translational medicine |d 2012 |g 13(2023), 11 vom: 29. Nov., Seite e1456 |w (DE-627)NLM224642685 |x 2001-1326 |7 nnns |
| 773 | 1 | 8 | |g volume:13 |g year:2023 |g number:11 |g day:29 |g month:11 |g pages:e1456 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1002/ctm2.1456 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 13 |j 2023 |e 11 |b 29 |c 11 |h e1456 | ||